Hugo Thomas Torquil Mackenzie-Smith

Hugo Thomas Torquil Mackenzie-Smith

Direktor/Vorstandsmitglied bei Ellenborough Park Hotel

52 Jahre
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Hugo Thomas Torquil Mackenzie-Smith

EinheitArt der EinheitIndustrie
9
Subsidiary Biotechnology 9
2
Subsidiary Hotels/Resorts/Cruise lines 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Hugo Thomas Torquil Mackenzie-Smith

UnternehmenSektorVerknüpfte PersonenHauptposition
ELI LILLY AND COMPANY Pharmaceuticals: Major

Richard Davies

Corporate Officer/Principal

Food Retail

Andy Clarke

Chief Executive Officer

MANNKIND CORPORATION Pharmaceuticals: Major

James Shannon

Chairman

Food Retail

Andy Clarke

Chief Executive Officer

Pharmaceuticals: Other

James Shannon

Director/Board Member

NEXIMMUNE, INC. Pharmaceuticals: Major

Jerome Zeldis

Chief Tech/Sci/R&D Officer

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Pharmaceuticals: Major

James Shannon

Director/Board Member

GSK PLC Pharmaceuticals: Major

James Shannon

Chief Tech/Sci/R&D Officer

Investment Managers

Anthony J. Bolton

Portfolio Manager-Equities

UCB Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

MASSMART HOLDINGS LIMITED Specialty Stores

Andy Clarke

Director/Board Member

MEDIGENE AG Biotechnology

Selwyn Ho

Chief Executive Officer

BIOTIE THERAPIES CORP Pharmaceuticals: Major

James Shannon

Director/Board Member

Imperial College London College/University

Selwyn Ho

Undergraduate Degree

Food Retail

Andy Clarke

Chief Executive Officer

Electronics/Appliances

James Shannon

Corporate Officer/Principal

Queen's University of Belfast College/University

James Shannon

Doctorate Degree

Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

ENDOCYTE, INC. Pharmaceuticals: Major

James Shannon

Director/Board Member

Pharmaceuticals: Major

James Shannon

General Counsel

The Royal College of Physicians College/University

James Shannon

Corporate Officer/Principal

BONESUPPORT HOLDING AB Medical Specialties

Richard Davies

Chief Executive Officer

Pharmaceuticals: Major

James Shannon

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Andy Clarke

President

Pharmaceuticals: Major

James Shannon

Chairman

Financial Conglomerates

Guido Urbach

Director/Board Member

Pharmaceuticals: Major

James Shannon

Director/Board Member

DERMIRA, INC. Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

Medical Specialties

Richard Davies

Chief Executive Officer

PROQR THERAPEUTICS N.V. Pharmaceuticals: Major

James Shannon

Chairman

Miscellaneous Commercial Services

James Shannon

Chairman

Real Estate Development

Richard Davies

Chairman

Investment Managers

Jerome Zeldis

Consultant / Advisor

Pharmaceuticals: Major

Richard Davies

Director/Board Member

XILIO THERAPEUTICS, INC. Pharmaceuticals: Major

James Shannon

Director/Board Member

Packaged Software

Richard Davies

Chief Executive Officer

Pharmaceuticals: Major

Jerome Zeldis

Director/Board Member

Miscellaneous Commercial Services

Richard Davies

Chief Executive Officer

Biotechnology

Gertjan Bartlema

Chief Executive Officer

Pharmaceuticals: Major

Jerome Zeldis

Chairman

CONNECT BIOPHARMA HOLDINGS LIMITED Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

Artemis Catalyst Ltd.

Selwyn Ho

Founder

Miscellaneous Commercial Services

James Shannon

Director/Board Member

ALVOTECH Biotechnology

Richard Davies

Director/Board Member

Mytommorows

James Shannon

Director/Board Member

Amgen Australia Pty Ltd.

Richard Davies

Corporate Officer/Principal

Statistik

International

Vereinigtes Königreich 16
Vereinigte Staaten 13
Niederlande 7
Schweden 4
Schweiz 4

Sektoral

Health Technology 31
Retail Trade 5
Finance 5
Consumer Services 4
Commercial Services 4

Operativ

Director/Board Member 67
Corporate Officer/Principal 25
Independent Dir/Board Member 24
Chairman 21
Chief Executive Officer 14
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT